- |||||||||| Biomarker, Enrollment open, Trial initiation date, Trial primary completion date, MSi-H Biomarker, PD(L)-1 Biomarker: MODUL: A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) (clinicaltrials.gov) - Jun 1, 2015
P2, N=610, Recruiting, Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Apr 2015 | Trial primary completion date: Nov 2020 --> Mar 2019
- |||||||||| 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg.
New P2 trial: HR Combined With FOLFOX4 for HCC With PVTT (clinicaltrials.gov) - May 26, 2015 P2, N=51, Active, not recruiting,
- |||||||||| Avastin (bevacizumab) / Roche
Trial primary completion date, Combination therapy, Metastases: Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Apr 29, 2015 P1, N=18, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> May 2015 Trial primary completion date: Mar 2015 --> Oct 2015
- |||||||||| TheraSphere (yttrium 90 microspheres) / Boston Scientific
Enrollment change, Trial primary completion date: Phase II Trial Evaluating OS With Therasphere (clinicaltrials.gov) - Apr 23, 2015 P2, N=9, Active, not recruiting, No longer recruiting --> Completed N=58 --> 9 | Trial primary completion date: May 2015 --> Dec 2015
|